General Information of the Protein
Protein ID |
PT05455
|
||||
---|---|---|---|---|---|
Protein Name |
Transforming growth factor beta-1 proprotein
|
||||
Gene Name |
TGFB1
|
||||
Secondarily Gene Name |
TGFB
|
||||
Sequence |
MPPSGLRLLPLLLPLLWLLVLTPGRPAAGLSTCKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGEVPPGPLPEAVLALYNSTRDRVAGESAEPEPEPEADYYAKEVTRVLMVETHNEIYDKFKQSTHSIYMFFNTSELREAVPEPVLLSRAELRLLRLKLKVEQHVELYQKYSNNSWRYLSNRLLAPSDSPEWLSFDVTGVVRQWLSRGGEIEGFRLSAHCSCDSRDNTLQVDINGFTTGRRGDLATIHGMNRPFLLLMATPLERAQHLQSSRHRRALDTNYCFSSTEKNCCVRQLYIDFRKDLGWKWIHEPKGYHANFCLGPCPYIWSLDTQYSKVLALYNQHNPGASAAPCCVPQALEPLPIVYYVGRKPKVEQLSNMIVRSCKCS
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Secreted protein
|
||||
Function |
Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Secreted
Extracellular space
Extracellular matrix
|
Clinical Information about the Protein
Target 1 ( Transforming growth factor beta 1 (TGFB1) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Idiopathic pulmonary fibrosis [ICD-11: CB03.4] | ||||
2 | Arteriosclerosis [ICD-11: BD40] | ||||
Approved Drug(s) | 1 Approved Drug | 1 | |||
1 | Pirfenidone | Approved | |||
Clinical Trial Drug(s) | 1 Clinical Trial Drug | 1 | |||
1 | LY2157299 | Phase 2/3 |
Target 2 ( TGFB1 messenger RNA (TGFB1 mRNA) )
Target Type | Literature-reported Target |
---|